KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Cost of Revenue: 2009-2025

Historic Cost of Revenue for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $572.6 million.

  • Charles River Laboratories International's Cost of Revenue rose 0.69% to $572.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 15.36%. This contributed to the annual value of $2.3 billion for FY2024, which is 2.17% up from last year.
  • Per Charles River Laboratories International's latest filing, its Cost of Revenue stood at $572.6 million for Q3 2025, which was down 2.09% from $584.9 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Cost of Revenue high stood at $664.8 million for Q3 2023, and its period low was $318.5 million during Q4 2023.
  • Moreover, its 3-year median value for Cost of Revenue was $578.2 million (2024), whereas its average is $579.7 million.
  • In the last 5 years, Charles River Laboratories International's Cost of Revenue slumped by 47.19% in 2023 and then skyrocketed by 95.13% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Cost of Revenue (Quarterly) stood at $468.1 million in 2021, then climbed by 28.85% to $603.1 million in 2022, then tumbled by 47.19% to $318.5 million in 2023, then spiked by 95.13% to $621.5 million in 2024, then rose by 0.69% to $572.6 million in 2025.
  • Its Cost of Revenue was $572.6 million in Q3 2025, compared to $584.9 million in Q2 2025 and $577.4 million in Q1 2025.